If your doctor tries to get you off the shots in favor of oral B12 supplements (tablets, spray, etc), do not accept that as treatment
BPC-157 complements these mechanisms through its activation of VEGFR2 and eNOS pathways that promote angiogenesis and improve endothelial function, with the peptide's nitric oxide generation supporting vasodilation and reducing thrombotic risk while its growth factor sensitization enhances vascular responses to ischemic conditions
Czimmerer et al., 2023) BPC-157 Structure CAS # 137525-51-0 Molecular Formula: CHNO Molecular Weight: 1419.53 g/mol Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val PubChem ID: 9941958 TB-500 Structure: CAS # 77591-33-4 Molecular Formula: CHNOS Molecular Weight: 4963.49 g/mol Sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Asn-Gly-Glu-Gly-Asp-Asn-Pro-Al Scientific studies of BPC-157 and TB-500 have focused on their cellular repair and anti-inflammatory potential within laboratory models
Patients will see an immediate result that will improve over the next six months
B vitamin therapy for homocysteine: renal function and vitamin B12 determine cardiovascular outcomes
If you are in Miami or Doral and considering BPC-157, the safe path is the same one we use with every peptide patient: a consultation, a clinical evaluation, and a protocol built around your specific situation and monitored over time
